Skip to content

Sanwei joint plaster in the treatment of knee osteoarthritis with qi stagnation and blood stasis in the early and middle stage: a randomized controlled clinical trial

Sanwei joint plaster in the treatment of knee osteoarthritis with qi stagnation and blood stasis in the early and middle stage: a randomized controlled clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083731
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Combination Therapy Group:Sanwei joint paste combined with Celebrex was used for external application
Topical Chinese medicine group:Sanwei joint paste was applied externally
Oral NSAIDs:Celebrex was given orally

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? The patients met the diagnostic criteria of western medicine and the syndrome differentiation criteria of traditional Chinese medicine for knee osteoarthritis, and were unilateral. ? Age 50-75 years old; ?4 =VAS score < 8 points ? If K-L grade was ?-?, the X-ray grade was referred to K-L imaging grading method. ? voluntarily participate and sign the informed consent form, and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: ? Swollen and hot knees. ? metabolic bone disease, serious cardiovascular disease, gastrointestinal disease and other serious diseases. (3) pregnant, preparing to become pregnant, or lactating women, and mentally ill patients. ? patients with knee trauma or surgery in the past 6 months. And ? patients who were allergic to any component of the study drug Sanwei joint paste. ? patients with skin damage or skin diseases at the drug application site. ? Patients who could not take the prescribed medication and receive the treatment, poor compliance, unable to judge the efficacy or incomplete treatment, which affected the efficacy and safety judgment.

Design outcomes

Primary

MeasureTime frame
VAS;Duration of pain relief;Time to disappearance of pain;Response rate for pain symptoms;

Secondary

MeasureTime frame
Clinical effective rate;TCM syndrome score;Western Ontario and McMaster Osteoarthritis Index;Depth of knee joint effusion;Synovial depth of the knee joint;Knee range of motion;Tenderness thresholds around the knee joint;Assessment of gait;Incidence of adverse events;

Countries

China

Contacts

Public ContactPing Wang

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

yfywangping@sina.com+86 136 0217 9933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026